(Q35848312)

10 August 2017

1 reference

title

Metallothionein expression in human neoplasia (English)

1 reference

10 August 2017

Theocharis SE

1

1 reference

10 August 2017

Margeli AP

series ordinal

2

1 reference

10 August 2017

Klijanienko JT

series ordinal

3

1 reference

10 August 2017

Kouraklis GP

series ordinal

4

1 reference

10 August 2017

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

103-118

1 reference

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

CTG triplet repeat in mouse growth inhibitory factor/metallothionein III gene promoter represses the transcriptional activity of the heterologous promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Basal metallothionein in tumors: widespread presence of apoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Inhibitory sites in enzymes: zinc removal and reactivation by thionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Reaction of a platinum(IV) complex with native Cd,Zn-metallothionein in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Specific induction of metallothionein synthesis by mitochondrial oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Significance of metallothionein overexpression in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Role of cysteine residues in regulation of p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Role of metallothionein in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein Is a Potential Negative Regulator of Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein in radiation exposure: its induction and protective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Expression of metallothionein in colorectal cancers and synchronous liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Role of metallothioneins in irradiated human rectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression in carcinoma of the gallbladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

New markers for pancreatic islets and islet cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Expression of metallothionein in lung carcinoma: correlation with histological type and grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Protein expression profiles indicative for drug resistance of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression in renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Treatment of renal stones by extracorporeal shockwave lithotripsy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

In vivo gene expression profile analysis of metallothionein in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothioneins in human kidneys and associated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Significance of metallothionein expression in breast myoepithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein isoform expression by breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein 2A expression is associated with cell proliferation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein levels in ovarian tumours before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Correlation of drug resistance-associated parameters in ovarian tumor biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein overexpression in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

Influence of metallothionein-1 localization on its function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01922.X

10.1111/J.1365-2559.2004.01922.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference